Search Result "Atherogenic indices"
PPAR Agonists, Atherogenic Dyslipidemia and Cardiovascular Risk
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 6 Year: 2017 Page: 894-902
Author(s): Dragana Nikolic,Giuseppa Castellino,Maciej Banach,Peter P. Toth,Ekaterina Ivanova,Alexander N. Orekhov,Giuseppe Montalto,Manfredi Rizzo
The Anti-Atherogenic Effects of Thiazolidinediones
Journal: Current Diabetes Reviews
Volume: 3 Issue: 1 Year: 2007 Page: 67-74
Author(s): Lily Stojanovska, Suzy Y. Honisett, Paul A. Komesaroff
Novel Monocyte Biomarkers of Atherogenic Conditions
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 5859-5864
Author(s): Alexei Gratchev, Ilja Ovsiy, Ioannis Manousaridis, Vladimir Riabov, Alexander Orekhov, Julia Kzhyshkowska
Blood Serum Atherogenicity: Cellular Test for the Development of Anti- Atherosclerotic Therapy
Journal: Current Pharmaceutical Design
Volume: 23 Issue: 8 Year: 2017 Page: 1195-1206
Author(s): Veronika A. Myasoedova,Galina A. Ivashinnikova,Igor A. Sobenin,Ekaterina A. Ivanova,Alexander N. Orekhov
The Atherogenic Dyslipidemia of Metabolic Syndrome- Are there New Effective Therapeutic Options Beyond Statins?
Journal: Current Drug Therapy
Volume: 2 Issue: 3 Year: 2007 Page: 177-195
Author(s): Giovanni Anfossi, Mariella Trovati
“European Panel on Low Density Lipoprotein (LDL) Subclasses”: A Statement on the Pathophysiology, Atherogenicity and Clinical Significance of LDL Subclasses
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 5 Year: 2011 Page: 533-571
Author(s): Dimitri P. Mikhailidis, Moses Elisaf, Manfredi Rizzo, Kaspar Berneis, Bruce Griffin, Alberto Zambon, Vasilios Athyros, Jacqueline de Graaf, Winfried Marz, Klaus G. Parhofer, Giovam Battista Rini, Giatgen A. Spinas, Gerald H. Tomkin, Alexandros D. Tselepis, Anthony S. Wierzbicki, Karl Winkler, Matilda Florentin, Evangelos Liberopoulos
Anti-Atherogenic Role of Peroxisome Proliferator-Activated Receptor Ligands
Journal: Current Cardiology Reviews
Volume: 1 Issue: 2 Year: 2005 Page: 89-102
Author(s): Julie Nigro, Mandy L. Ballinger, Narin Osman, Anthony M. Dart, Peter J. Little
Cross-talk Between Exogenous Statins and Endogenous High-Density Lipoprotein in Anti-Inflammatory and Anti-Atherogenic Actions
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 10 Issue: 1 Year: 2010 Page: 8-15
Author(s): Takao Kimura, Koichi Sato, Hideaki Tomura, Fumikazu Okajima
Atherogenic Index of Plasma in Women with Rheumatoid Arthritis and Systemic Lupus Erythematosus: A 10-Year Potential Predictor of Cardiovascular Disease
Journal: Current Rheumatology Reviews
Volume: 17 Issue: 1 Year: 2021 Page: 122-130
Author(s): Nevin Hammam,Noha Abdel-Wahab,Tamer A Gheita
A Review of the Cardiovascular and Anti-Atherogenic Effects of Ghrelin
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 27 Year: 2013 Page: 4953-4963
Author(s): Manfredi Rizzo,Ali A. Rizvi,Emina Sudar,Sanja Soskic,Milan Obradovic,Giuseppe Montalto,Mohamed Boutjdir,Dimitri P. Mikhailidis,Esma R. Isenovic